

Instance: composition-en-test-citalopram
InstanceOf: CompositionUvEpi
Title: "Composition for citalopram Package Leaflet"
Description:  "Composition for citalopram Package Leaflet"
Usage: #inline


* identifier.system = "http://ema.europa.eu/identifier"
* identifier.value = "test-citalopram"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* author.display = "EMA"
* date = "2022-02-16T13:28:17Z"

* title = "TEST PURPOSES ONLY - citalopram"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"
* subject = Reference(test-citalopram-mpd)


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What citalopram is and what it is used for </li>
<li>What you need to know before you use citalopram  </li>
<li>How to use citalopram </li>
<li>Possible side effects </li>
<li>How to store citalopram </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What citalopram is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What citalopram is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>citalopram is a modern insulin (insulin analogue) with a rapid-acting effect. Modern insulin products 
are improved versions of human insulin. </p>
<p>citalopram is used to reduce the high blood sugar level in adults, adolescents and children aged 1 year 
and above with diabetes mellitus (diabetes). Diabetes is a disease where your body does not produce 
enough insulin to control the level of your blood sugar. Treatment with citalopram helps to prevent 
complications from your diabetes. </p>
<p>citalopram will start to lower your blood sugar 10 20 minutes after you inject it, a maximum effect 
occurs between 1 and 3 hours after the injection and the effect lasts for 3 5 hours. Due to this short 
action citalopram should normally be taken in combination with intermediate-acting or long-acting 
insulin preparations. Moreover citalopram can be used for continuous infusion in a pump system. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take citalopram"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take citalopram"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not use citalopram  </p>
<p>If you are allergic to insulin aspart, or any of the other ingredients in this medicine (see section 
6, Contents of the pack and other information). </p>
<p>If you suspect hypoglycaemia (low blood sugar) is starting (see a) Summary of serious and very 
common side effects in section 4). </p>
<p>If the protective cap is loose or missing. Each vial has a protective, tamper-proof plastic cap. If 
it is not in perfect condition when you get the vial, return the vial to your supplier. </p>
<p>If it has not been stored correctly or been frozen (see section 5, How to store citalopram). </p>
<p>If the insulin does not appear clear and colourless. </p>
<p>If any of these applies, do not use citalopram. Talk with your doctor, nurse or pharmacist for advice. </p>
<p>Before using citalopram </p>
<p>Check the label to make sure it is the right type of insulin. </p>
<p>Remove the protective cap. </p>
<p>Always use a new needle for each injection to prevent contamination. </p>
<p>Needles and syringes must not be shared. </p>
<p>Warnings and precautions </p>
<p>Some conditions and activities can affect your need for insulin. Consult your doctor: </p>
<p>If you have trouble with your kidneys or liver, or with your adrenal, pituitary or thyroid glands.  </p>
<p>If you exercise more than usual or if you want to change your usual diet, as this may affect your 
blood sugar level. </p>
<p>If you are ill, carry on taking your insulin and consult your doctor. </p>
<p>If you are going abroad, travelling over time zones may affect your insulin needs and the timing 
of your injections. </p>
<p>Skin changes at the injection site </p>
<p>The injection site should be rotated to help prevent changes to the fatty tissue under the skin, such as 
skin thickening, skin shrinking or lumps under the skin. The insulin may not work very well if you 
inject into a lumpy, shrunken or thickened area (see section 3, How to use citalopram). Tell your 
doctor if you notice any skin changes at the injection site. Tell your doctor if you are currently 
injecting into these affected areas before you start injecting in a different area. Your doctor may tell 
you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic 
medications dose. </p>
<p>Children and adolescents </p>
<p>Do not give this medicine to children below 1 year of age since no clinical studies have been carried 
out in children below the age of 1 year. </p>
<p>Other medicines and citalopram </p>
<p>Tell your doctor, nurse or pharmacist if you are taking, have recently taken or might take any other 
medicines. 
Some medicines affect your blood sugar level and this may mean that your insulin dose has to change. 
Listed below are the most common medicines which may affect your insulin treatment. </p>
<p>Your blood sugar level may fall (hypoglycaemia) if you take: 
* Other medicines for the treatment of diabetes 
* Monoamine oxidase inhibitors (MAOI) (used to treat depression) 
* Beta-blockers (used to treat high blood pressure) 
* Angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high 
blood pressure) 
* Salicylates (used to relieve pain and lower fever) 
* Anabolic steroids (such as testosterone) 
* Sulphonamides (used to treat infections). </p>
<p>Your blood sugar level may rise (hyperglycaemia) if you take: 
* Oral contraceptives (birth control pills) 
* Thiazides (used to treat high blood pressure or excessive fluid retention) 
* Glucocorticoids (such as  cortisone  used to treat inflammation) 
* Thyroid hormones (used to treat thyroid gland disorders) 
* Sympathomimetics (such as epinephrine [adrenaline], or salbutamol, terbutaline used to treat 
asthma) 
* Growth hormone (medicine for stimulation of skeletal and somatic growth and pronounced 
influence on the body s metabolic processes) 
* Danazol (medicine acting on ovulation). </p>
<p>Octreotide and lanreotide (used for treatment of acromegaly, a rare hormonal disorder that usually 
occurs in middle-aged adults, caused by the pituitary gland producing excess growth hormone) may 
either increase or decrease your blood sugar level. </p>
<p>Beta-blockers (used to treat high blood pressure) may weaken or suppress entirely the first warning 
symptoms which help you to recognise low blood sugar. </p>
<p>Pioglitazone (tablets used for the treatment of type 2 diabetes) 
Some patients with long-standing type 2 diabetes and heart disease or previous stroke who were 
treated with pioglitazone and insulin experienced the development of heart failure. Inform your doctor 
as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid 
increase in weight or localised swelling (oedema). </p>
<p>If you have taken any of the medicines listed here, tell your doctor, nurse or pharmacist. </p>
<p>Drinking alcohol and taking citalopram </p>
<p>If you drink alcohol, your need for insulin may change as your blood sugar level may either rise 
or fall. Careful monitoring is recommended. </p>
<p>Pregnancy and breast-feeding </p>
<p>If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor 
for advice before taking this medicine. citalopram can be used during pregnancy. Your insulin 
dose may need to be changed during pregnancy and after delivery. Careful control of your 
diabetes, particularly prevention of hypoglycaemia, is important for the health of your baby. </p>
<p>There are no restrictions on treatment with citalopram during breast-feeding. </p>
<p>Ask your doctor, nurse or pharmacist for advice before taking this medicine while pregnant or breast-
feeding. </p>
<p>Driving and using machines </p>
<p>Please ask your doctor whether you can drive a car or operate a machine: 
* If you have frequent hypoglycaemia.<br />
* If you find it hard to recognise hypoglycaemia. </p>
<p>If your blood sugar is low or high, your concentration and ability to react might be affected and 
therefore also your ability to drive or operate a machine. Bear in mind that you could endanger 
yourself or others. </p>
<p>citalopram has a rapid onset of effect therefore if hypoglycaemia occurs, you may experience it earlier 
after an injection when compared to soluble human insulin. </p>
<p>Important information about some of the ingredients of citalopram </p>
<p>citalopram contains less than 1 mmol sodium (23 mg) per dose, i.e. citalopram is essentially 
 sodium-free . </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take citalopram"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take citalopram"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dose and when to take your insulin </p>
<p>Always use your insulin and adjust your dose exactly as your doctor has told you. Check with your 
doctor, nurse or pharmacist if you are not sure. </p>
<p>citalopram is generally taken immediately before a meal. Eat a meal or snack within 10 minutes of the 
injection to avoid low blood sugar. When necessary, citalopram can be given soon after a meal. See 
How and where to inject below for information. </p>
<p>Do not change your insulin unless your doctor tells you to. If your doctor has switched you from one 
type or brand of insulin to another, your dose may have to be adjusted by your doctor.  </p>
<p>Use in children and adolescents </p>
<p>citalopram can be used in adolescents and children aged 1 year and above instead of soluble human 
insulin when a rapid onset of effect is preferred. For example, when it is difficult to dose the child in 
relation to meals.  </p>
<p>Use in special patient groups </p>
<p>If you have reduced kidney or liver function, or if you are above 65 years of age, you need to check 
your blood sugar more regularly and discuss changes in your insulin dose with your doctor. </p>
<p>How and where to inject </p>
<p>citalopram is for injection under the skin (subcutaneously) or for continuous infusion in a pump 
system. Administration in a pump system will require a comprehensive instruction by your healthcare 
professional. You must never inject yourself directly into a vein (intravenously) or muscle 
(intramuscularly). If necessary citalopram can be given directly into a vein but this must only be done 
by physicians or other healthcare staff. </p>
<p>With each injection, change the injection site within the particular area of skin that you use. This may 
reduce the risk of developing lumps or skin pitting (see section 4, Possible side effects). The best 
places to give yourself an injection are: the front of your waist (abdomen), the upper arm or the front 
of your thighs. The insulin will work more quickly if injected into the front of your waist. You should 
always measure your blood sugar regularly. </p>
<p>NPH (Neutral Protamine Hagedorn) insulin is the only type of insulin that can be mixed with 
citalopram and the mixture must be injected immediately under your skin (subcutaneously). 
citalopram should be drawn into the syringe before you draw your NPH insulin. </p>
<p>How to take citalopram </p>
<p>If you use only one type of insulin 
1. Draw into the syringe the same amount of air as the dose of insulin you are going to inject. 
Inject the air into the vial. 
2. Turn the vial and syringe upside down and draw the correct insulin dose into the syringe. Pull 
the needle out of the vial. Then expel the air from the syringe and check that the dose is correct. </p>
<p>If you have to mix two types of insulin 
1. Just before use, roll the NPH insulin between your hands until the liquid is uniformly white and 
cloudy. 
2. Draw into the syringe the same amount of air as the dose of the NPH insulin. Inject the air into 
the vial containing the NPH insulin and pull out the needle. 
3. Draw into the syringe the same amount of air as the dose of citalopram. Inject the air into the 
vial containing citalopram. Turn the vial and syringe upside down and draw up the prescribed 
dose of citalopram. Expel any air from the syringe and check that the dose is correct. 
4. Push the needle into the vial of the NPH insulin, turn the vial and syringe upside down and draw 
out the dose you have been prescribed. Expel any air from the syringe and check the dose. Inject 
the mixture immediately. 
5. Always mix citalopram and the NPH insulin in the same sequence. </p>
<p>How to inject citalopram </p>
<p>Inject the insulin under the skin. Use the injection technique advised by your doctor or nurse. </p>
<p>Keep the needle under your skin for at least 6 seconds to make sure you have injected all the 
insulin. </p>
<p>Discard the needle after each injection. </p>
<p>For use in an infusion pump system </p>
<p>citalopram should never be mixed with any other insulin when used in a pump.<br />
Follow the instructions and recommendations from your doctor regarding the use of citalopram in a 
pump. Before use of citalopram in the pump system, you must have received a comprehensive 
instruction in the use and information about any actions to be taken in case of illness, too high or too 
low blood sugar or failure of the pump system.<br />
* Before inserting the needle, use soap and water to clean your hands and the skin where the 
needle is inserted to avoid any infection at the infusion site. 
* When you fill a new reservoir, be certain not to leave large air bubbles in either the syringe or 
the tubing. 
* Changing of the infusion set (tubing and needle) must be done according to the instructions in 
the product information supplied with the infusion set. </p>
<p>To get the benefit of insulin infusion, and to detect possible malfunction of the insulin pump, it is 
recommended that you measure your blood sugar level regularly. </p>
<p>What to do in case of pump system failure </p>
<p>You should always have an alternative delivery method for your insulin available for injection under 
the skin in case of pump system failure. </p>
<p>If you take more insulin than you should </p>
<p>If you take too much insulin your blood sugar gets too low (hypoglycaemia). See a) Summary of 
serious and very common side effects in section 4. If you forget to take your insulin </p>
<p>If you forget to take your insulin your blood sugar may get too high (hyperglycaemia). See c) Effects 
from diabetes in section 4. If you stop taking your insulin </p>
<p>Do not stop taking your insulin without speaking with a doctor, who will tell you what needs to be 
done. This could lead to very high blood sugar (severe hyperglycaemia) and ketoacidosis. See c) 
Effects from diabetes in section 4. If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>a) 
Summary of serious and very common side effects  </p>
<p>Low blood sugar (hypoglycaemia) is a very common side effect. It may affect more than 1 in people. </p>
<p>Low blood sugar may occur if you: 
* Inject too much insulin. 
* Eat too little or miss a meal. 
* Exercise more than usual. 
* Drink alcohol (see Drinking alcohol and taking citalopram in section 2). </p>
<p>Signs of low blood sugar: Cold sweat; cool pale skin; headache; rapid heartbeat; feeling sick; feeling 
very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness 
or tremor; feeling anxious; feeling confused; difficulty in concentrating. </p>
<p>Severe low blood sugar can lead to unconsciousness. If prolonged severe low blood sugar is not 
treated, it can cause brain damage (temporary or permanent) and even death. You may recover more 
quickly from unconsciousness with an injection of the hormone glucagon by someone who knows how 
to use it. If you are given glucagon, you will need glucose or a sugar snack as soon as you are 
conscious. If you do not respond to glucagon treatment, you will have to be treated in a hospital. </p>
<p>What to do if you experience low blood sugar: </p>
<p>If you experience low blood sugar, eat glucose tablets or another high sugar snack (e.g. sweets, 
biscuits, fruit juice). Measure your blood sugar if possible and rest. Always carry glucose tablets 
or high sugar snacks with you, just in case. </p>
<p>When symptoms of low blood sugar have disappeared or when blood sugar level is stabilised, 
continue insulin treatment as usual. </p>
<p>If you have such a low blood sugar that it makes you pass out, if you have had need for injection 
of glucagon, or if you have experienced many incidents of low blood sugar, talk with a doctor. 
The amount or timing of insulin, food or exercise may need to be adjusted. </p>
<p>Tell relevant people that you have diabetes and what the consequences may be, including the risk of 
passing out (become unconscious) due to low blood sugar. Let them know that if you pass out, they 
must turn you on your side and get medical help straight away. They must not give you any food or 
drink due to risk of suffocation. </p>
<p>Serious allergic reactions to citalopram or one of its ingredients (called a systemic allergic reaction) 
is a very rare side effect but can potentially be life threatening. It may affect less than 1 in 10,people. </p>
<p>Seek medical advice immediately: 
* If signs of allergy spread to other parts of your body. 
* If you suddenly feel unwell, and you: start sweating; start being sick (vomiting); have difficulty 
in breathing; have a rapid heartbeat; feel dizzy. </p>
<p>If you notice any of these signs, seek medical advice immediately. </p>
<p>Skin changes at the injection site: If you inject insulin at the same place, the fatty tissue may shrink 
(lipoatrophy) or thicken (lipohypertrophy) (may affect less than 1 in 100 people). Lumps under the 
skin may also be caused by build-up of a protein called amyloid (cutaneous amyloidosis; how often 
this occurs is not known). The insulin may not work very well if you inject into a lumpy, shrunken or 
thickened area. Change the injection site with each injection to help prevent these skin changes. </p>
<p>b) 
List of other side effects </p>
<p>Uncommon side effects 
May affect less than 1 in 100 people. </p>
<p>Signs of allergy: Local allergic reactions (pain, redness, hives, inflammation, bruising, swelling and 
itching) at the injection site may occur. These usually disappear after a few weeks of taking your 
insulin. If they do not disappear, or if they spread throughout your body, talk to your doctor 
immediately. See also Serious allergic reactions above. </p>
<p>Vision problems: When you first start your insulin treatment, it may disturb your vision, but the 
disturbance is usually temporary. </p>
<p>Swollen joints: When you start taking insulin, water retention may cause swelling around your ankles 
and other joints. Normally this soon disappears. If not, talk to your doctor. </p>
<p>Diabetic retinopathy (an eye disease related to diabetes which can lead to loss of vision): If you have 
diabetic retinopathy and your blood sugar level improves very fast, the retinopathy may get worse. 
Ask your doctor about this. </p>
<p>Rare side effects<br />
May affect less than 1 in 1,000 people. </p>
<p>Painful neuropathy (pain due to nerve damage): If your blood sugar level improves very fast, you may 
get nerve related pain. This is called acute painful neuropathy and is usually transient. </p>
<p>Reporting of side effects </p>
<p>If you get any side effects, talk with your doctor, nurse or pharmacist. This includes any possible side 
effects not listed in this leaflet. You can also report side effects directly via the national reporting 
system listed in Appendix V. By reporting side effects you can help provide more information on the 
safety of this medicine. </p>
<p>c) 
Effects from diabetes  </p>
<p>High blood sugar (hyperglycaemia) </p>
<p>High blood sugar may occur if you: 
* Have not injected enough insulin. 
* Forget to inject your insulin or stop taking insulin. 
* Repeatedly inject less insulin than you need. 
* Get an infection and/or a fever. 
* Eat more than usual. 
* Exercise less than usual. </p>
<p>Warning signs of high blood sugar: 
The warning signs appear gradually. They include: increased urination; feeling thirsty; losing your 
appetite; feeling sick (nausea or vomiting); feeling drowsy or tired; flushed; dry skin; dry mouth and a 
fruity (acetone) smell of the breath. </p>
<p>What to do if you experience high blood sugar: </p>
<p>If you get any of the above signs: test your blood sugar level, test your urine for ketones if you 
can, then seek medical advice immediately. </p>
<p>These may be signs of a very serious condition called diabetic ketoacidosis (build-up of acid in 
the blood because the body is breaking down fat instead of sugar). If you do not treat it, this 
could lead to diabetic coma and eventually death. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store citalopram"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store citalopram"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. 
Do not use this medicine after the expiry date which is stated on the vial label and carton, after  EXP . 
The expiry date refers to the last day of that month. 
Keep the vial in the outer carton in order to protect it from light.  </p>
<p>Before opening: Store in a refrigerator at 2 C to 8 C, away from the cooling element. Do not freeze. </p>
<p>During use or when carried as a spare: The product may be stored for a maximum of 4 weeks. Store 
below 30 C. Do not refrigerate or freeze. </p>
<p>Discard the needle after each injection. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What citalopram contains </p>
<ul>
<li>The active substance is insulin aspart. Each ml contains 100 units of insulin aspart. Each vial 
contains 1,000 units of insulin aspart in 10 ml solution for injection. </li>
<li>The other ingredients are glycerol, phenol, metacresol, zinc chloride, disodium phosphate 
dihydrate, sodium chloride, hydrochloric acid, sodium hydroxide and water for injections. </li>
</ul>
<p>What citalopram looks like and contents of the pack </p>
<p>citalopram is presented as a solution for injection. </p>
<p>Pack sizes of 1 or 5 vials of 10 ml or a multipack of 5 packs of 1 x 10 ml vial. Not all pack sizes may 
be marketed. </p>
<p>The solution is clear and colourless.  </p>
<p>Marketing Authorisation Holder and Manufacturer </p>
<p>Novo Nordisk A/S, Novo All , DK-2880 Bagsv rd, Denmark </p>
<p>This leaflet was last revised in  </p>
<p>Other sources of information  </p>
<p>Detailed information on this medicine is available on the European Medicines Agency website: 
http://www.ema.europa.eu. 
Package leaflet: Information for the user </p>
<p>citalopram Penfill 100 units/ml solution for injection in cartridge<br />
insulin aspart </p>
<p>Read all of this leaflet carefully before you start using this medicine because it contains 
important information for you. </p>
<ul>
<li>Keep this leaflet. You may need to read it again. </li>
<li>If you have any further questions, ask your doctor, nurse or pharmacist. </li>
<li>This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, 
even if their signs of illness are the same as yours. </li>
<li>If you get any side effects, talk with your doctor, nurse or pharmacist. This includes any 
possible side effects not listed in this leaflet. See section 4.</li>
</ul>         </div>"""      



Instance: test-citalopram-mpd
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "test citalopram mpd"
Description: "test citalopram mpd"
Usage: #inline

 
* identifier[+].system = "https://www.gravitatehealth.eu/sid/doc" 
* identifier[=].value = "test-citalopram"
* identifier[+].system = $spor-man
* identifier[=].value = "204447"
* identifier[+].system = $spor-man
* identifier[=].value = "1115009" // WADA

* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"


* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"


* name
  * productName = "citalopram 20 mg tablets"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "citalopram FlexPen"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "Insulin"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "100 units/ml"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "solution for injection in pre-filled pens"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#GBR "United Kingdom"
    * jurisdiction = urn:iso:std:iso:3166#GBR "United Kingdom"
    * language = urn:ietf:bcp:47#en  "English"




RuleSet: citalopram-ruleset 


// Composition
* entry[+].fullUrl = "http://hl7.eu/fhir/ig/gravitate-health/Composition/test-citalopram-mpd"
* entry[=].resource = test-citalopram-mpd


Instance: bundle-citalopram-raw
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for citalopram Flexpen 100 units/ml solution for injection in pre-filled pen Package Leaflet for language en"
Description: "ePI document Bundle for citalopram Flexpen 100 units/ml solution for injection in pre-filled pen Package Leaflet for language en"
Usage: #example


* identifier.system = "https://www.gravitatehealth.eu/sid/doc" 
* identifier.value = "test-citalopram"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en


// Composition
* entry[0].fullUrl = "http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-en-test-citalopram"
* entry[0].resource = composition-en-test-citalopram


* insert citalopram-ruleset



RuleSet: test-citalopram-ruleset


* identifier[+].system = "https://www.gravitatehealth.eu/sid/doc" 
* identifier[=].value = "xx"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "citalopram"

* status = #current
* mode = #working

* title = "List of all ePIs associated with citalopram"



* subject = Reference(test-citalopram-mpd)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#ibuprofen "citalopram"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundle-citalopram-raw) // Nurofen 100 mg Chewa en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  //* item.extension[=].valueCoding = $100000072057#100000072147 "English"
  * item.extension[=].valueCoding = $100000072057#en "en"

* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#02
  * flag.text = "preprocessed"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundle-citalopram-proc) // amoxicillin 250 mg t en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  //* item.extension[=].valueCoding = $100000072057#100000072147 "English"
  * item.extension[=].valueCoding = $100000072057#en "en"



Instance: List-citalopram-test
InstanceOf: List

* insert test-citalopram-ruleset



//// PREPROC ////

Instance: bundle-citalopram-proc
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for citalopram Flexpen 100 units/ml solution for injection in pre-filled pen Package Leaflet for language es"
Description: "ePI document Bundle for citalopram Flexpen 100 units/ml solution for injection in pre-filled pen Package Leaflet for language es"
Usage: #example

* identifier.system = "https://www.gravitatehealth.eu/sid/doc" 
* identifier.value = "test-citalopram"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-en-citalopram-psroc"
* entry[0].resource = composition-en-citalopram-proc

* insert citalopram-ruleset




Instance: composition-en-citalopram-proc
InstanceOf: CompositionUvEpi
Title: "Composition for citalopram Package Leaflet"
Description:  "Composition for citalopram Package Leaflet"
Usage: #inline


* identifier.system = "https://www.gravitatehealth.eu/sid/doc" 
* identifier.value = "epibundle-123"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* author.display = "EMA"
* date = "2022-02-16T13:28:17Z"

* title = "TEST PURPOSES ONLY - semaglutide"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#P "Processed"
* subject = Reference(test-citalopram-mpd)



/*
* extension[+].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink"
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "indication"
* extension[=].extension[+].url = "concept"
* extension[=].extension[=].valueCodeableReference.concept.coding = http://snomed.info/sct#238131007 ""



// doping properties
//  const WADA_BUNDLE_IDENTIFIER_LIST = ["epibundle-123", "epibundle-abc"];
//  const WADA_LIST = [  "1115009", // Example: Testosterone "1234567", // Example: Erythropoietin (EPO) "204432",  // Example: Clenbuterol "360147"   // Example: Oxandrolone ];
//  let listOfCategoriesToSearch = ["grav-2"]; //what to look in extension to find class

* extension[+].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink"
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "doping-properties"
* extension[=].extension[+].url = "concept"
* extension[=].extension[=].valueCodeableReference.concept.coding = http://gravitate-health.eu/codes#grav-2 "Doping Properties"


//contact-lens 
//    let arrayOfClasses = [{ "code": "grav-4", "system": "https://www.gravitatehealth.eu/sid/doc" }]      //what to look in extensions -made up code because there is none
//generalPractitioner with contact email or phone
* extension[+].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink"
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "contact-link-place"
* extension[=].extension[+].url = "concept"
* extension[=].extension[=].valueCodeableReference.concept.coding = http://gravitate-health.eu/codes#grav-4 "Contact place"

//    let listOfCategoriesToSearch = [{"code":"grav-1","system":"http://gravitate-health.eu/codes"}]; //what to look in extensions -made up code because there is none
// const potassiumCodes = ["2823-3", "6298-4"]; // what to look in IPS Lab || <3.5
//    const citalopramKeywords = ["citalopram", "Citalopram"]; // what to look in medication request / statements
//    const citalopramCodes = ["204447", "372729009"];// what to look in medication request / statements
* extension[+].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink"
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "qt-prolongation-risk"
* extension[=].extension[+].url = "concept"
* extension[=].extension[=].valueCodeableReference.concept.coding = http://gravitate-health.eu/codes#grav-1 "QT Prolongation Risk"


//    const BUNDLE_IDENTIFIER_LIST = ["epibundle-123", "epibundle-abc"];
//    const PRODUCT_IDENTIFIER_LIST = ["CIT-204447", "RIS-197361"];
//    let listOfCategoriesToSearch = ["grav-3"]; //what to look in extensions -made up code because there is none
//gh-questionnaire-lens
* extension[+].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink"
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "questionnaire"
* extension[=].extension[+].url = "concept"
* extension[=].extension[=].valueCodeableReference.concept.coding = http://gravitate-health.eu/codes#grav-3 "questionnaire"


//gh-test-lab-lens // needs eGFRCodes ["48643-1", "33914-3", "62238-1"] < 30
* extension[+].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink"
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "lab-lens-egfr"
* extension[=].extension[+].url = "concept"
* extension[=].extension[=].valueCodeableReference.concept.coding = http://snomed.info/sct#709044004 "lab lens"

*/





// last resource processed
* extension[+].extension[0].url = "lens"
* extension[=].extension[=].valueCodeableReference.reference = Reference(Library/indication-lens)
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "indication-lens"
* extension[=].extension[+].url = "explanation"
* extension[=].extension[=].valueString = "This is the objective of the medicine you are taking."
* extension[=].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/LensesApplied"



* extension[+].extension[0].url = "lens"
* extension[=].extension[=].valueCodeableReference.reference = Reference(Library/conditions-lens)
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "conditions-lens"
* extension[=].extension[+].url = "explanation"
* extension[=].extension[=].valueString = "This section was highlighted because you have diabetes and overweigth. This will help you!"
* extension[=].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/LensesApplied"



* extension[+].extension[0].url = "lens"
* extension[=].extension[=].valueCodeableReference.reference = Reference(Library/doping-lens)
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "doping-lens"
* extension[=].extension[+].url = "explanation"
* extension[=].extension[=].valueString = "Be carefull this drug is on the doping list. Athletes should check before use it."
* extension[=].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/LensesApplied"




* extension[+].extension[0].url = "lens"
* extension[=].extension[=].valueCodeableReference.reference = Reference(Library/community-lens)
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "community-lens"
* extension[=].extension[+].url = "explanation"
* extension[=].extension[=].valueString = "Please consider joining a community of patients with your condition. It will help you!"
* extension[=].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/LensesApplied"


* extension[+].extension[0].url = "lens"
* extension[=].extension[=].valueCodeableReference.reference = Reference(Library/questionnaire-lens)
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "questionnaire-lens"
* extension[=].extension[+].url = "explanation"
* extension[=].extension[=].valueString = "Please consider filling out a questionnaire to help your medical team understand your condition and health status better."
* extension[=].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/LensesApplied"





* extension[+].extension[0].url = "lens"
* extension[=].extension[=].valueCodeableReference.reference = Reference(Library/contact-lens)
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "contact-lens"
* extension[=].extension[+].url = "explanation"
* extension[=].extension[=].valueString = "Please, contact your healthcare provider if you have any questions about this medicine."
* extension[=].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/LensesApplied"


* extension[+].extension[0].url = "lens"
* extension[=].extension[=].valueCodeableReference.reference = Reference(Library/qt-prolongation-lens)
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "qt-prolongation-lens"
* extension[=].extension[+].url = "explanation"
* extension[=].extension[=].valueString = "Citalopram may prolong your QT interval. Please, inform your doctor if you have any heart condition."
* extension[=].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/LensesApplied"

* extension[+].extension[0].url = "lens"
* extension[=].extension[=].valueCodeableReference.reference = Reference(Library/lab-lens)
* extension[=].extension[+].url = "elementClass"
* extension[=].extension[=].valueString = "lab-lens"
* extension[=].extension[+].url = "explanation"
* extension[=].extension[=].valueString = "[eFGR] Please, take into account your kidney function when taking this medicine. Talk with your doctor."
* extension[=].url = "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/LensesApplied"





* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  
  <h2>semaglutide FlexTouch 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg</h2><h2>
  Solution for injection in pre-filled pen</h2><h2>
  Semaglutide</h2>

  <p><strong>This medicine is subject to additional monitoring.</strong> This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of Section 4 for how to report side effects.</p>

  <p>Read all of this leaflet carefully before you start using this medicine because it contains important information for you.</p>
  <ul>
    <li>Keep this leaflet. You may need to read it again.</li>
    <li>If you have any further questions, ask your doctor, pharmacist or nurse.</li>
    <li>This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.</li>
    <li>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See Section 4.</li>
  </ul>
       </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>    <ol>
    <li>What semaglutide is and what it is used for</li>
    <li>What you need to know before you use semaglutide</li>
    <li>How to use semaglutide</li>
    <li>Possible side effects</li>
    <li>How to store semaglutide</li>
    <li>Contents of the pack and other information</li>
  </ol>
   </div>"""   
          

* section[=].section[+]
  * title =  "1. What semaglutide is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What semaglutide is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h3>What semaglutide is</h3>
  <p class="indication highlight conditions-lens">semaglutide is a medicine for weight loss and weight maintenance that contains the active substance semaglutide. It is similar to a natural hormone called glucagon-like peptide-1 (GLP-1) that is released from the intestine after a meal. semaglutide works by acting on receptors in the brain that control your appetite, causing you to feel fuller and less hungry and experience less craving for food. This will help you eat less food and reduce your body weight. semaglutide should be used with a reduced calorie meal plan and increased physical activity.</p>

  <h3>What semaglutide is used for</h3>
  <p><strong>Weight management</strong></p><p>
  semaglutide is used for weight loss and weight maintenance in addition to diet and physical activity in adults, who have:
  <ul>
    <li>a BMI of 30 kg/m¬≤ or greater (obesity), or</li>
    <li>a BMI of 27 kg/m¬≤ and less than 30 kg/m¬≤ (overweight) and weight-related health problems.</li>
  </ul>
  BMI (Body Mass Index) is a measure of your weight in relation to your height.</p>
  <p>semaglutide is used together with diet and physical activity for weight management in adolescents aged 12 years and above, who have:
  <ul>
    <li>obesity, and</li>
    <li>body weight &gt; 60 kg.</li>
  </ul>
  As an adolescent patient, you should only continue using semaglutide if you have lost at least 5% of your BMI after 12 weeks on the 2.4 mg dose or maximum tolerated dose (see Section 3). Consult your doctor before you continue.</p>

  <p><strong>Risk reduction of serious heart issues in adults</strong></p><p>
  semaglutide is used in addition to diet and physical activity to reduce the risk of serious heart issues (heart-related death, heart attacks, strokes) in adults with a history of heart disease (like a heart attack, stroke or poor blood flow to the limbs) and either obesity or overweight (BMI ‚â• 27 kg/m¬≤).</p>

<p class="community-lens"  style="background-color:#f9edbe;padding:10px 15px;border:1px solid #e0c97f;position:relative;margin-bottom:10px;">
  <a href="https://www.diabetesteam.com/">You are not alone! üì¢ Please check this community to connect with peers!</a></p>


     </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take semaglutide"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take semaglutide"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'> 
          <div class="alert-banner questionnaire-lens" style="background-color:#ffdddd;padding:1em;border:1px solid #ff8888;margin-bottom:1em;">
          ‚ö†Ô∏è This medication may cause high-risk side effects.
          <a href="https://sandbox.hl7europe.eu/gh-questionnaire.html" target="_blank" style="margin-left: 1em;">Fill out safety questionnaire</a>
        </div>

  <p><strong>Do not use semaglutide if you are:</strong></p>
  <ul>
    <li class="doping-properties highlight doping-lens">allergic to semaglutide or any of the other ingredients of this medicine (listed in Section 6).</li>
  </ul>

  <h3>Warnings and precautions</h3>
  <p>Talk to your doctor, pharmacist or nurse before using semaglutide or during treatment if you have:</p>
  <ul>
    <li><strong>Effects on the digestive system</strong>
      During treatment with semaglutide, you may feel sick (nausea) or be sick (vomiting), or have diarrhoea. These side effects can cause dehydration (loss of fluids). It is important that you drink enough fluids to prevent dehydration. This is especially important if you have kidney problems. Talk to your doctor if you have any questions or concerns.</li>

    <li class="qt-prolongation-risk highlight qt-prolongation-lens"><strong>Inflammation of the pancreas</strong>
      If you have severe and ongoing pain in the stomach area, see a doctor straight away as this could be a sign of inflamed pancreas (acute pancreatitis).</li>

    <li><strong>Diabetes</strong>
      semaglutide must not be used as a substitute for insulin.</li>

    <li><strong>Low blood sugar (hypoglycaemia)</strong>
      semaglutide can cause low blood sugar. Please see Section 4 for the warning signs of low blood sugar levels. If you have diabetes and are taking a sulfonylurea or insulin with semaglutide, the risk of getting low blood sugar levels (hypoglycaemia) might increase. Your doctor may ask you to test your blood sugar levels. This will help your doctor decide if the dose of the sulfonylurea or insulin needs to be changed to reduce the risk of low blood sugar.</li>

    <li><strong>Diabetic eye disease (retinopathy)</strong>
      Fast improvements in blood sugar control may lead to a temporary worsening of diabetic eye disease. If you have diabetic eye disease and experience eye problems while taking this medicine, talk to your doctor.</li>

    <li>If you know that you are due to have surgery where you will be under anaesthesia (sleeping), please tell your doctor that you are taking semaglutide.</li>
  </ul>

  <h3>Children and adolescents</h3>
  <p>The safety and efficacy of semaglutide in children below 12 years of age have not been studied and are not recommended for use in this population.</p>

  <h3>Other medicines and semaglutide</h3>
  <p>Tell your doctor, pharmacist or nurse if you are using, have recently used or might use any other medicines.</p>

  <h3>Pregnancy and breast-feeding</h3>
  <p>This medicine should not be used during pregnancy, as it is not known if it may affect your unborn child. Therefore, it is recommended to use contraception while using this medicine. If you wish to become pregnant, you should stop using this medicine at least two months in advance. If you become or are pregnant, think you may be pregnant or are planning to have a baby when using this medicine, talk to your doctor straight away, as your treatment will need to be stopped.</p>
  <p>You should not use this medicine if you are breastfeeding, as it is unknown if it passes into breast milk.</p>

  <h3>Driving and using machines</h3>
  <p>semaglutide is unlikely to affect your ability to drive and use machines. Some patients may feel dizzy when taking semaglutide mainly during the first 3 months of treatment (see Section 4). If you feel dizzy you should not drive or operate machines until you feel better. If you need any further information, talk to your doctor, pharmacist or nurse.</p>
  <p>For diabetics using this medicine in combination with a sulfonylurea or insulin, low blood sugar (hypoglycaemia) may occur which may reduce your ability to concentrate. Do not drive or use machines if you get any signs of low blood sugar. See Section 2, ‚ÄòWarnings and precautions‚Äô for information on increased risk of low blood sugar and Section 4 for the warning signs of low blood sugar. Talk to your doctor for further information.</p>

  <h3>Sodium content</h3>
  <p>This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‚Äòsodium-free‚Äô.</p>

   </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take semaglutide"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take semaglutide"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always use this medicine exactly as your doctor has told you. <span class="highlight contact-lens" href="mailto:me@example.org">Check with your doctor, pharmacist or nurse if you are not sure.</span></p>

  <h3>How much to use</h3>

  <h4>Adults</h4>
  <p>The recommended dose is 2.4 mg once weekly.
  Your treatment will start at a low dose which will be gradually increased over 16 weeks of treatment as follows:
  <ul>
    <li>When you first start using semaglutide, the starting dose is 0.25 mg once weekly.</li>
    <li class="lab-lens-egfr highlight lab-lens">Your doctor will instruct you to gradually increase your dose every 4 weeks until you reach the recommended dose of 2.4 mg once weekly.</li>
    <li>Once you reach the recommended dose of 2.4 mg, do not increase this dose further.</li>
  </ul>
  You will be told to follow the table below:</p>

  <table border="1" cellpadding="5" cellspacing="0">
    <caption><strong>Dose escalation</strong></caption>
    <thead>
      <tr>
        <th>Weeks</th>
        <th>Weekly dose</th>
      </tr>
    </thead>
    <tbody>
      <tr>
        <td>Week 1‚Äì4</td>
        <td>0.25 mg</td>
      </tr>
      <tr>
        <td>Week 5‚Äì8</td>
        <td>0.5 mg</td>
      </tr>
      <tr>
        <td>Week 9‚Äì12</td>
        <td>1 mg</td>
      </tr>
      <tr>
        <td>Week 13‚Äì16</td>
        <td>1.7 mg</td>
      </tr>
      <tr>
        <td>From week 17</td>
        <td>2.4 mg</td>
      </tr>
    </tbody>
  </table>
  <p>Your doctor will assess your treatment on a regular basis.</p>

  <h4>Adolescents (aged 12 years and above)</h4>
  <p>For adolescents, the same dose escalation schedule as for adults should be applied (see above). The dose should be increased until 2.4 mg (maintenance dose) or maximum tolerated dose has been reached. Weekly doses higher than 2.4 mg are not recommended.</p>

  <h3>How semaglutide is given</h3>
  <p>semaglutide is given as an injection under the skin (subcutaneous injection). Do not inject it into a vein or muscle.</p>
  <ul>
    <li>The best places to give the injection are the upper arms, stomach or upper legs.</li>
    <li>Before you use the pen for the first time, ask your doctor or nurse how to use it.</li>
  </ul>
  <p>Detailed instructions for use are on the other side of this leaflet.</p>

  <h3>People with diabetes</h3>
  <p>Tell your doctor if you have diabetes. Your doctor may adjust the dose of your diabetes medicines to prevent you from getting low blood sugar.</p>
  <ul>
    <li>Do not mix semaglutide with other medicines that you inject (e.g. insulins).</li>
    <li>Do not use semaglutide in combination with other medicines that contain GLP-1 receptor agonists (such as liraglutide, dulaglutide, exenatide or lixisenatide).</li>
  </ul>

  <h3>When to use semaglutide</h3>
  <ul>
    <li>You should use this medicine once a week and, if possible, on the same day each week.</li>
    <li>You can give yourself the injection at any time of the day ‚Äì regardless of meals.</li>
  </ul>
  <p>If necessary, you can change the day of your weekly injection of this medicine as long as it has been at least 3 days since your last injection. After selecting a new dosing day, continue with once-a-week dosing.</p>

  <h3>If you use more semaglutide than you should</h3>
  <p>Talk to your doctor straight away. You may get side effects such as feeling sick (nausea).</p>

  <h3>If you forget to use semaglutide</h3>
  <p>If you forgot to inject a dose and:</p>
  <ul>
    <li>It is 5 days or less since you should have used semaglutide, use it as soon as you remember. Then inject your next dose as usual on your scheduled day.</li>
    <li>It is more than 5 days since you should have used semaglutide, skip the missed dose. Then inject your next dose as usual on your next scheduled day. Do not take a double dose to make up for a forgotten dose.</li>
  </ul>

  <h3>If you stop using semaglutide</h3>
  <p>Do not stop using this medicine without talking to your doctor.</p>
  <p>If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</p>
        </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>

  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p>

  <h3>Serious side effects</h3>

  <h4>Common: may affect up to 1 in 10 people</h4>
  <ul>
    <li>Complications of diabetic eye disease (diabetic retinopathy). If you have diabetes, you should inform your doctor if you experience eye problems, such as changes in vision, during treatment with this medicine.</li>
  </ul>

  <h4>Uncommon: may affect up to 1 in 100 people</h4>
  <ul>
    <li>Inflamed pancreas (acute pancreatitis). Signs of inflamed pancreas may include severe and long-lasting pain in your stomach; the pain may move to your back. You should see your doctor immediately if you experience such symptoms.</li>
    <li>Kidney or bladder stones. Signs may include back or lower abdomen pain, difficulty in urination or change in colour of your urine.</li>
  </ul>

  <h4>Rare: may affect up to 1 in 1,000 people</h4>
  <ul>
    <li>Severe allergic reactions (anaphylactic reactions, angioedema). You should seek immediate medical help and inform your doctor straight away if you get symptoms such as breathing problems, swelling of face, lips, tongue, and/or throat with difficulty swallowing, wheezing, fast heartbeat, pale and cold skin, feeling dizzy or weak.</li>
    <li>Hip fractures.</li>
  </ul>

  <h4>Not known (frequency cannot be estimated from the available data)</h4>
  <ul>
    <li>Bowel obstruction. A severe form of constipation with additional symptoms such as stomach ache, bloating, vomiting, etc.</li>
  </ul>

  <h3>Other side effects</h3>

  <h4>Very common: may affect more than 1 in 10 people</h4>
  <ul>
    <li>Headache</li>
    <li>Feeling sick (nausea)</li>
    <li>Being sick (vomiting)</li>
    <li>Diarrhoea</li>
    <li>Constipation</li>
    <li>Stomach pain</li>
    <li>Feeling weak or tired</li>
  </ul>
  <p>These usually go away over time.</p>

  <h4>Common: may affect up to 1 in 10 people</h4>
  <ul>
    <li>Feeling dizzy</li>
    <li>Upset stomach or indigestion</li>
    <li>Burping</li>
    <li>Gas (flatulence)</li>
    <li>Bloating of the stomach</li>
    <li>Inflamed stomach (‚Äògastritis‚Äô) ‚Äì the signs include stomach ache, feeling sick (nausea) or being sick (vomiting)</li>
    <li>Reflux or heartburn ‚Äì also called ‚Äògastro-oesophageal reflux disease‚Äô</li>
    <li>Gallstones</li>
    <li>Hair loss</li>
    <li>Injection site reactions</li>
    <li>Change in the way food or drink tastes</li>
    <li>Change in skin sensation</li>
    <li>Low blood sugar (hypoglycaemia) in patients with diabetes</li>
  </ul>
  <p>The warning signs of low blood sugar may come on suddenly. They can include: cold sweat, cool pale skin, headache, fast heartbeat, feeling sick (nausea) or very hungry, changes in vision, feeling sleepy or weak, feeling nervous, anxious or confused, difficulty concentrating or shaking. Your doctor will tell you how to treat low blood sugar and what to do if you notice these warning signs. Low blood sugar is more likely to happen if you also take a sulfonylurea or insulin. Your doctor may reduce your dose of these medicines before you start using this medicine.</p>

  <h4>Uncommon: may affect up to 1 in 100 people</h4>
  <ul>
    <li>Fast heartbeat</li>
    <li>Increase of pancreatic enzymes (such as lipase and amylase) shown in blood tests</li>
    <li>A delay in the emptying of the stomach</li>
    <li>Low blood sugar (hypoglycaemia) in patients without diabetes</li>
    <li>Increased levels of bilirubin in your blood. Signs include jaundice which is yellowing of the skin or the whites of your eyes.</li>
  </ul>

  <h3>Reporting of side effects</h3>
  <p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: <a href="https://yellowcard.mhra.gov.uk/" target="_blank" rel="noopener noreferrer">https://yellowcard.mhra.gov.uk/</a> or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.</p>


   </div>"""      
        
* section[=].section[+]
  * title = "5. How to store semaglutide"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store semaglutide"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <ul>
    <li>Keep this medicine out of the sight and reach of children.</li>
    <li>Do not use this medicine after the expiry date which is stated on the pen label and carton after ‚ÄòEXP‚Äô. The expiry date refers to the last day of that month.</li>
    <li>Do not freeze semaglutide and do not use it if it has been frozen.</li>
    <li>Keep the pen cap on in order to protect from light.</li>
  </ul>

  <h3>Before opening:</h3>
  <p>Store in a refrigerator (2 ¬∞C to 8 ¬∞C). Keep away from the cooling element.</p>

  <h3>During use:</h3>
  <p>You can keep the pen for 6 weeks when stored at a temperature below 30 ¬∞C or in a refrigerator (2 ¬∞C to 8 ¬∞C) away from the cooling element.</p>
  <p>Do not use this medicine if you notice that the solution is not clear and colourless.</p>
  <p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>

      </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'> 
  <h3>What semaglutide contains</h3>
  <ul>
    <li><strong>The active substance</strong> is semaglutide.</li>
    <li><strong>The other ingredients</strong> are disodium phosphate dihydrate, propylene glycol, phenol, sodium hydroxide/hydrochloric acid (for pH adjustment), water for injection.</li>
  </ul>

  <h4>semaglutide 0.25 mg FlexTouch solution for injection</h4>
  <p>One mL of solution contains 0.68 mg of semaglutide. One pre-filled pen contains 1.0 mg semaglutide in 1.5 mL solution.</p>

  <h4>semaglutide 0.5 mg FlexTouch solution for injection</h4>
  <p>One mL of solution contains 1.34 mg of semaglutide. One pre-filled pen contains 2.0 mg semaglutide in 1.5 mL solution.</p>

  <h4>semaglutide 1 mg FlexTouch solution for injection</h4>
  <p>One mL of solution contains 1.34 mg of semaglutide. One pre-filled pen contains 4.0 mg semaglutide in 3 mL solution.</p>

  <h4>semaglutide 1.7 mg FlexTouch solution for injection</h4>
  <p>One mL of solution contains 2.27 mg of semaglutide. One pre-filled pen contains 6.8 mg semaglutide in 3 mL solution.</p>

  <h4>semaglutide 2.4 mg FlexTouch solution for injection</h4>
  <p>One mL of solution contains 3.2 mg of semaglutide. One pre-filled pen contains 9.6 mg of semaglutide in 3 mL solution.</p>

  <h3>What semaglutide looks like and contents of the pack</h3>
  <p>semaglutide is a clear and colourless solution for injection in a pre-filled disposable pen.</p>
  <p>Each FlexTouch pen contains four doses. The pack size of each strength of semaglutide contains 1 pre-filled pen and 4 disposable NovoFine¬Æ Plus needles.</p>
  <p>Your pen is designed to be used with NovoFine¬Æ Plus, NovoFine¬Æ or NovoTwist¬Æ disposable needles up to a length of 8 mm.</p>

  <h3>Marketing Authorisation Holder</h3>
  <p>Novo Nordisk A/S</p><p>
  Novo All√©</p><p>
  DK-2880 Bagsv√¶rd</p><p>
  Denmark</p>

  <h3>Manufacturer</h3>
  <p>Novo Nordisk A/S</p><p>
  Novo All√©</p><p>
  DK-2880 Bagsv√¶rd</p><p>
  Denmark</p>
  <p>Novo Nordisk Production SAS</p><p>
  45, Avenue d‚ÄôOrl√©ans</p><p>
  28000 Chartres</p><p>
  France</p>

  <p>This leaflet was last revised in 10/2024.</p>
     </div>"""      
